Medical Ingenuities Company Profile

Background

Medical Ingenuities, LLC, established in 2011 and headquartered in Wheaton, Illinois, is a medical device company dedicated to developing innovative solutions that enhance patient care and improve healthcare system efficiency. The company's flagship product, the PH Band™ Radial Closure System, is designed to address complications associated with radial artery occlusion following trans-radial procedures.

Key Strategic Focus

Medical Ingenuities focuses on creating simple and innovative radial artery closure solutions. The PH Band™ is engineered for easy application, streamlined workflow, and real-time feedback to ensure radial artery patency. By providing audible Doppler feedback, the device assists medical personnel in monitoring blood flow, thereby reducing the risk of occlusion-related complications and minimizing the need for frequent pressure adjustments.

Financials and Funding

The company has secured funding to support its product development and commercialization efforts. In May 2021, Medical Ingenuities closed its Series Seed Preferred round, with cultivate(MD) Seed II Fund as the lead investor. This investment facilitated the regulatory process, validation, and testing required for FDA submission.

Pipeline Development

The PH Band™ Radial Closure System received FDA 510(k) clearance in December 2020, allowing for its clinical use. Following this clearance, the company initiated its market launch, focusing on key opinion leader hospitals within ten healthcare systems where new physicians are trained in the radial access approach.

Technological Platform and Innovation

The PH Band™ stands out due to its integration of real-time Doppler feedback, enabling audible detection of antegrade flow past the compression point. This feature ensures patent hemostasis and reduces the need for manual pressure adjustments. The device's design emphasizes ease of use, with features like easy Doppler unit alignment and a dual-band design to enhance usability and effectiveness.

Leadership Team

Chip Corrigan, CEO: With over 25 years of experience, Chip has been instrumental in launching more than 25 medical devices across six startups and has held senior roles at publicly traded cardiology device companies.

Tony Olivito, COO: Tony brings extensive experience in finance, supply chain, and operations for multi-billion dollar private companies, along with a background in advising and investing in startups.

Chris Littel, CMO: An Army veteran with 25 years in medtech, Chris has held senior leadership roles in sales, marketing, and product development at Johnson & Johnson and two startup companies.

Competitor Profile

Market Insights and Dynamics

The radial artery closure device market is integral to interventional cardiology, focusing on minimizing complications post-trans-radial procedures. The demand for devices ensuring patent hemostasis and reducing radial artery occlusion is growing, driven by the increasing adoption of radial access in cardiac catheterization.

Competitor Analysis

Terumo Corporation: A global leader in medical devices, Terumo offers a range of vascular closure devices and has a significant presence in the radial access market.

Teleflex Incorporated: Teleflex provides various vascular access solutions, including devices aimed at improving patient outcomes and reducing complications associated with radial artery procedures.

Strategic Collaborations and Partnerships

In the fall of 2020, Medical Ingenuities participated in the gBeta Medtech program, sponsored by Boston Scientific, DRIVe, and University Enterprise Labs. This collaboration provided valuable mentorship and resources, aiding in the company's development and commercialization efforts.

Operational Insights

Medical Ingenuities differentiates itself through the PH Band™'s real-time Doppler feedback feature, which ensures patent hemostasis and reduces the need for manual pressure adjustments. This innovation addresses a critical need in the market, positioning the company as a leader in radial artery closure solutions.

Strategic Opportunities and Future Directions

The company aims to expand its market presence by targeting key healthcare systems and training centers, promoting the adoption of the PH Band™. Future plans include developing additional products that align with their mission to provide simple and innovative solutions that advance patient care and enhance healthcare system efficiency.